Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam
The LTT is a sensitive marker of drug sensitization that could be used to inform future patient management. Desensitization is associated with attenuation of the piperacillin-specific T-cell response.
Authors
- Andrew Gibson (ORCID: https://orcid.org/0000-0001-9653-3298)
- Lindsey Gillgrass
- John Farrell (ORCID: https://orcid.org/0000-0002-8726-5997)
- Xiaoli Meng (ORCID: https://orcid.org/0000-0002-7774-2075)
- D. Peckham (ORCID: https://orcid.org/0000-0001-7723-1868)
- Dean John Naisbitt (ORCID: https://orcid.org/0000-0003-4107-7832)
- Paul Whitaker (ORCID: https://orcid.org/0000-0001-9840-393X)
Institutions
- University of Liverpool (GB)
- St James's University Hospital (GB)
Publication Details
- Journal
- The Journal of Allergy and Clinical Immunology In Practice
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1016/j.jaip.2024.12.003
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Cystic Fibrosis Trust
- Medical Research Council